Psoriasis trial brings Advitech's XP-828L launch closer
Canadian biotech company Advitech has come a step closer to launching whey-derived XP-828L as an oral alternative to conventional drugs for psoriasis sufferers with the announcement of positive results in a clinical trial to test its safety and...